Jose Bufill is an expert in the field of Hematology. He attended Medical College of Wisconsin Affiliated Hospitals. He has 1 awards "Fellow (FACP)". Jose Bufill is a published MD. He has 2 papers published. The most current publication "Phase II Trial of Erlotinib and Docetaxel in Advanced and Refractory Hepatocellular and Biliary Cancers: Hoosier Oncology Group GI06-101." He accepts Medicare payments and is registered with Medicare.gov.
NPI NUMBER | 1558365031 | |
NPPES Provider LastName | BUFILL | |
NPPES Provider FirstName | JOSE | |
NPPES Provider ZIPCode | 465451470 | |
NPPES Provider State | IN | |
Specialty Description | Medical Oncology | |
Total Claim Count | 1268.0 | |
Distinct Opioid Count | 5.0 | |
Opioid Claim Count | 142.0 | |
Percent Opioid Claims | 11.2 |
National Provider Identifier [NPI] | 1558365031 |
Last Name Of The Provider | BUFILL |
First Name Of The Provider | JOSE |
View All |
Dr. Ahsanul Haque, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. William D. Pletcher, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. James O. Jin, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Musaberk Goksel, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Patrick T. Williams, MD |